# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040803
Filing Date
2023-11-14
Accepted
2023-11-14 09:00:32
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1209353
2 |  | ex31-1.htm | EX-31.1 | 19691
3 |  | ex31-2.htm | EX-31.2 | 19844
4 |  | ex32-1.htm | EX-32.1 | 8171
| Complete submission text file | 0001493152-23-040803.txt |  | 5430243

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | imnn-20230930.xsd | EX-101.SCH | 46676
6 | XBRL CALCULATION FILE | imnn-20230930_cal.xml | EX-101.CAL | 62283
7 | XBRL DEFINITION FILE | imnn-20230930_def.xml | EX-101.DEF | 175789
8 | XBRL LABEL FILE | imnn-20230930_lab.xml | EX-101.LAB | 375084
9 | XBRL PRESENTATION FILE | imnn-20230930_pre.xml | EX-101.PRE | 286772
67 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 637288

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 231401910
SIC: 2834 Pharmaceutical Preparations